NEUTROLIS INC.
BiotechnologyBiotechnology
Cambridge, MA
About
Neutrolis Inc. is a clinical-stage biotechnology firm that specializes in developing innovative therapies aimed at autoimmune and inflammatory diseases. The company's unique approach focuses on targeting Neutrophil Extracellular Traps (NETs), which are implicated in tissue damage and chronic inflammation associated with several immune-mediated disorders, such as lupus and dry eye disease, as well as severe complications from conditions like COVID-19.
Company Values
Neutrolis stands out by developing therapies that specifically target the harmful effects of NETs without broadly suppressing immune function.